Metropolitan Life Insurance Company (MetLife)’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,973
Closed -$1.33M 650
2024
Q1
$1.33M Sell
4,973
-43
-0.9% -$10.9K 0.06% 279
2023
Q4
$1.24M Sell
5,016
-61
-1% -$12.4K 0.06% 280
2023
Q3
$930K Sell
5,077
-268
-5% -$54.7K 0.05% 307
2023
Q2
$1.26M Sell
5,345
-134
-2% -$28.2K 0.06% 278
2023
Q1
$1.11M Sell
5,479
-1,463
-21% -$305K 0.06% 302
2022
Q4
$1.35M Sell
6,942
-86
-1% -$15.7K 0.06% 300
2022
Q3
$1.2M Sell
7,028
-84
-1% -$16.5K 0.06% 311
2022
Q2
$1.3M Sell
7,112
-161
-2% -$32.2K 0.06% 309
2022
Q1
$1.72M Sell
7,273
-8,558
-54% -$2.02M 0.06% 293
2021
Q4
$4.64M Sell
15,831
-537
-3% -$149K 0.06% 244
2021
Q3
$4.15M Sell
16,368
-536
-3% -$139K 0.06% 253
2021
Q2
$4.05M Sell
16,904
-2,679
-14% -$599K 0.06% 272
2021
Q1
$3.55M Sell
19,583
-1,087
-5% -$192K 0.05% 303
2020
Q4
$3.99M Sell
20,670
-827
-4% -$139K 0.06% 254
2020
Q3
$3.37M Sell
21,497
-878
-4% -$144K 0.06% 271
2020
Q2
$3.85M Sell
22,375
-394
-2% -$58.4K 0.07% 225
2020
Q1
$2.72M Sell
22,769
-295
-1% -$42.9K 0.06% 286
2019
Q4
$3.23M Sell
23,064
-74
-0.3% -$10.3K 0.05% 323
2019
Q3
$3.25M Buy
23,138
+3,527
+18% +$497K 0.06% 302
2019
Q2
$2.65M Buy
19,611
+1,275
+7% +$160K 0.04% 375
2019
Q1
$2.17M Sell
18,336
-649
-3% -$69.3K 0.04% 451
2018
Q4
$1.77M Sell
18,985
-63
-0.3% -$6.71K 0.04% 497
2018
Q3
$2.49M Sell
19,048
-610
-3% -$79.5K 0.04% 404
2018
Q2
$2.46M Sell
19,658
-4,284
-18% -$508K 0.04% 410
2018
Q1
$2.82M Buy
23,942
+109
+0.5% +$13.1K 0.04% 351
2017
Q4
$2.81M Sell
23,833
-38,324
-62% -$4.31M 0.04% 353
2017
Q3
$6.59M Sell
62,157
-727
-1% -$96.1K 0.04% 417
2017
Q2
$8.64M Sell
62,884
-874
-1% -$120K 0.06% 303
2017
Q1
$8.72M Sell
63,758
-812
-1% -$103K 0.06% 305
2016
Q4
$7.63M Sell
64,570
-1,600
-2% -$196K 0.05% 338
2016
Q3
$8.9M Sell
66,170
-665
-1% -$88.2K 0.07% 278
2016
Q2
$8.58M Sell
66,835
-514
-0.8% -$62.3K 0.06% 286
2016
Q1
$7.7M Sell
67,349
-792
-1% -$83.3K 0.06% 305
2015
Q4
$7.59M Sell
68,141
-1,047
-2% -$113K 0.06% 310
2015
Q3
$6.72M Sell
69,188
-1,575
-2% -$156K 0.05% 359
2015
Q2
$6.87M Buy
70,763
+2,130
+3% +$208K 0.05% 393
2015
Q1
$6.38M Sell
68,633
-1,457
-2% -$129K 0.05% 411
2014
Q4
$5.67M Sell
70,090
-464
-0.7% -$35.9K 0.04% 476
2014
Q3
$5.27M Sell
70,554
-1,236
-2% -$94.1K 0.04% 474
2014
Q2
$5.21M Sell
71,790
-5,577
-7% -$391K 0.04% 518
2014
Q1
$5.26M Sell
77,367
-990
-1% -$69.2K 0.04% 507
2013
Q4
$5.41M Sell
78,357
-1,282
-2% -$83.4K 0.04% 482
2013
Q3
$4.77M Sell
79,639
-236
-0.3% -$14.5K 0.04% 502
2013
Q2
$4.71M Buy
+79,875
New +$4.82M 0.04% 471

Other funds holding EFX

Metropolitan Life Insurance Company (MetLife)'s EFX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Equifax (EFX) in Q2 2024, closing a stake of 4,973 shares — an estimated $1.33M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EFX in Q2 2013 and held it in 44 quarters. The position peaked at $8.9M in Q3 2016. 758 funds tracked by Wall St. Rank hold EFX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Equifax position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,973 Equifax shares in Q2 2024, an estimated $1.33M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Equifax in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Equifax position peaked at $8.9M in Q3 2016.
  • 758 funds tracked by Wall St. Rank held Equifax as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.